Lobsor Pharmaceuticals Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Lobsor Pharmaceuticals General Information
Description
Developer of pharmaceutical drugs intended for the treatment of Parkinson's disease. The company offers treatment of Parkinson's disease in advanced stages especially continuous infusion of levodopa into the small intestine via a pump, that aims to improve daily living for individuals affected by progressive Parkinson's disease and is suitable for an invasive treatment.
Contact Information
Website
www.lobsor.com(Operating Subsidiary)
Corporate Office
- Kålsängsgränd 10 D
- 753 19 Uppsala
- Sweden
Corporate Office
- Kålsängsgränd 10 D
- 753 19 Uppsala
- Sweden
Lobsor Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lobsor Pharmaceuticals Comparisons
Industry
Financing
Details
Lobsor Pharmaceuticals Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioArctic | Formerly VC-backed | Stockholm, Sweden | ||||
| Keapstone Therapeutics | Venture Capital-Backed | Sheffield, United Kingdom |
Lobsor Pharmaceuticals Patents
Lobsor Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019237857-A1 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Pending | 23-Mar-2018 | ||
| EP-3768263-A1 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Pending | 23-Mar-2018 | ||
| JP-2021519272-A | Continuous administration of pharmaceutical compositions for the treatment of neurodegenerative disorders | Active | 23-Mar-2018 | ||
| US-20230157989-A1 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Pending | 23-Mar-2018 | ||
| JP-6889231-B2 | A pharmaceutical composition containing levodopa, a dopamine decarboxylase inhibitor and a comt inhibitor, and a method for administering the same. | Active | 04-Sep-2014 | A61K31/198 |
Lobsor Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Ulf Rosén | Co-Founder & Chief Executive Officer | |
| Roger Bolsöy | Co-Founder |
Lobsor Pharmaceuticals Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Board Member | ||
| Self | Board Member | ||
| Self | Board Member | ||
| Self | Board Member |
Lobsor Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lobsor Pharmaceuticals FAQs
-
When was Lobsor Pharmaceuticals founded?
Lobsor Pharmaceuticals was founded in 2013.
-
Who is the founder of Lobsor Pharmaceuticals?
Ulf Rosén and Roger Bolsöy are the founders of Lobsor Pharmaceuticals.
-
Who is the CEO of Lobsor Pharmaceuticals?
Ulf Rosén is the CEO of Lobsor Pharmaceuticals.
-
Where is Lobsor Pharmaceuticals headquartered?
Lobsor Pharmaceuticals is headquartered in Uppsala, Sweden.
-
What is the size of Lobsor Pharmaceuticals?
Lobsor Pharmaceuticals has 3 total employees.
-
What industry is Lobsor Pharmaceuticals in?
Lobsor Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Lobsor Pharmaceuticals a private or public company?
Lobsor Pharmaceuticals is a Private company.
-
What is the current valuation of Lobsor Pharmaceuticals?
The current valuation of Lobsor Pharmaceuticals is .
-
What is Lobsor Pharmaceuticals’s current revenue?
The current revenue for Lobsor Pharmaceuticals is .
-
Who are Lobsor Pharmaceuticals’s competitors?
BioArctic and Keapstone Therapeutics are competitors of Lobsor Pharmaceuticals.
-
When was Lobsor Pharmaceuticals acquired?
Lobsor Pharmaceuticals was acquired on 01-Sep-2020.
-
Who acquired Lobsor Pharmaceuticals?
Lobsor Pharmaceuticals was acquired by STADA Arzneimittel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
